Medicxi Growth I LP Amends Phathom Pharma Stake
Ticker: PHAT · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, beneficial-ownership
TL;DR
**Medicxi Growth I LP updated their Phathom Pharma ownership, watch for market reaction.**
AI Summary
Medicxi Growth I LP, a venture capital firm, filed an amended Schedule 13G/A on January 26, 2024, indicating a change in their beneficial ownership of Phathom Pharmaceuticals, Inc. common stock. This filing, triggered by an event on January 24, 2024, updates their previous disclosure regarding their investment in the pharmaceutical company. This matters to investors because significant changes in institutional ownership can signal shifts in confidence or investment strategy, potentially influencing stock price movements.
Why It Matters
Changes in institutional ownership can signal shifts in confidence or investment strategy, potentially influencing the stock price of Phathom Pharmaceuticals, Inc.
Risk Assessment
Risk Level: low — This filing is an update to an existing ownership disclosure and does not inherently signal a high-risk event, but rather a change in a known position.
Analyst Insight
An investor should monitor subsequent filings from Medicxi Growth I LP to understand the full scope of their updated position and consider if other institutional investors are making similar moves, as this could indicate a broader sentiment shift for Phathom Pharmaceuticals, Inc.
Key Players & Entities
- Medicxi Growth I LP (company) — reporting person and beneficial owner
- Phathom Pharmaceuticals, Inc. (company) — subject company (issuer)
- Medicxi Co-Invest IV LP (company) — group member
- Medicxi Growth Co-Invest I LP (company) — group member
- Medicxi Growth I GP Ltd (company) — group member
- Medicxi IV GP Ltd (company) — group member
- Medicxi IV LP (company) — group member
- Medicxi Ventures Management (Jersey) Ltd (company) — group member
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment (Amendment No. 2) to a Schedule 13G, indicating an update to the beneficial ownership information of Medicxi Growth I LP regarding Phathom Pharmaceuticals, Inc. common stock, as required by the Securities Exchange Act of 1934.
Who is the 'Reporting Person' in this filing?
The 'Reporting Person' identified in this filing is Medicxi Growth I LP, which is updating its beneficial ownership stake in Phathom Pharmaceuticals, Inc.
What is the 'Subject Company' of this filing?
The 'Subject Company' (or Issuer) is Phathom Pharmaceuticals, Inc., whose common stock is the subject of the beneficial ownership report.
When was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was January 24, 2024, as stated on the cover page of the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(c), as indicated by the checked box on the cover page.
Filing Stats: 2,430 words · 10 min read · ~8 pages · Grade level 8.6 · Accepted 2024-01-26 16:00:51
Key Financial Figures
- $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- d930770dsc13ga.htm (SC 13G/A) — 147KB
- d930770dex991.htm (EX-99.1) — 11KB
- 0001193125-24-016691.txt ( ) — 159KB
Ownership of Five Percent or Less of a Class
Item 5.Ownership of Five Percent or Less of a Class. If this
Ownership of More than Five Percent on Behalf of Another
Item 6.Ownership of More than Five Percent on Behalf of Another Person. Not applicable.
Identification and Classification of the Subsidiary Which
Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.
Identification and Classification of Members of the
Item 8.Identification and Classification of Members of the Group. Not applicable.
Notice of Dissolution of Group
Item 9.Notice of Dissolution of Group. Not applicable.
Certification
Item 10.Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. CUSIP No. 71722W107 SCHEDULE 13G Page 12 of 13 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 26, 2024 Medicxi Growth I LP By: /s/ Giles Johnstone-Scott Name: Giles Johnstone-Scott Title: Director For and on behalf of Medicxi Ventures Management (Jersey) Limited as manager of Medicxi Growth I LP Medicxi Growth Co-Invest I LP By: /s/ Giles Johnstone-Scott Name: Giles Johnstone-Scott Title: Director For and on behalf of Medicxi Ventures Management (Jersey) Limited as manager of Medicxi Growth Co-Invest I LP Medicxi Growth I GP Limited By: /s/ Nigel Crocker Name: Nigel Crocker Title: Alternate Director Medicxi IV LP By: /s/ Giles Johnstone-Scott Name: Giles Johnstone-Scott Title: Director For and on behalf of Medicxi Ventures Management (Jersey) Limited as manager of Medicxi IV LP Medicxi Co-Invest IV LP By: /s/ Giles Johnstone-Scott Name: Giles Johnstone-Scott Title: Director For and on behalf of Medicxi Ventures Management (Jersey) Limited as manager of Medicxi Co-Invest IV LP CUSIP No. 71722W107 SCHEDULE 13G Page 13 of 13 Pages Medicxi IV GP Limited By: /s/ Nigel Crocker Name: Nigel Crocker Title: Alternate Director Medicxi Ventures Management (Jersey) Limited By: /s/ Giles Johnstone-Scott Name: Giles Johnstone-Scott Title: